BofA Cuts Hims & Hers Price Target as Mixed Quarter Resets Street Expectations

Bank of America cut Hims & Hers’ price target to $30 from $32 while keeping a Neutral rating, citing a "mixed quarter" and elevated expectations. Q1 2026 revenue came in at $608.1 million versus $616.85 million consensus, and diluted EPS missed at -$0.40 versus $0.03 expected. The stock traded at $23.85 intraday, well below the revised target, as investors weigh margin compression, restructuring charges, and a reset in Street estimates.

Analysis

The key second-order effect here is not the earnings miss itself, but the forced de-rating process that tends to follow when a growth story loses narrative momentum while still carrying premium multiples. HIMS now has to digest a valuation that was built for compounding execution, yet the core monetization engine is being mechanically pressured by a mix shift toward lower-take-rate, more regulated products; that typically shows up as multiple compression before fundamentals stabilize. In that setup, analyst target cuts matter less as catalysts than as confirmation that sell-side models are still lagging the new base case.

The competitive implication is that larger incumbents with direct distribution and pharmacy leverage should be able to compete more efficiently on branded GLP-1 economics, while HIMS absorbs the transition cost and marketing burden. That creates a lagged margin headwind: even if subscriber growth re-accelerates, the mix may not support prior gross profit assumptions for several quarters. The upside case is that the international and adjacent-category expansion can offset the U.S. GLP-1 reset faster than investors expect, but that likely requires multiple quarters of clean execution rather than a single headline beat.

The main catalyst path is timing-based: near term, the stock likely trades on estimate revisions and sentiment repair, not absolute valuation. A reversal would need either a cleaner quarter with margin stabilization or evidence that new category expansion is producing higher-retention cohorts, which would give the market a reason to re-rate beyond the current reset. Until then, this is a classic setup where the stock can stay cheap for months even if the long-term thesis survives.

The contrarian view is that the market may be over-penalizing the transition because it is treating a business-model normalization as if it were a thesis break. If management can show that the post-pivot customer acquisition engine still monetizes with acceptable payback, the current compression may ultimately prove temporary. But with consensus still too high and the stock already below published targets, the burden of proof is on fundamentals, not valuation.

Key Decisions for Investors

• Avoid initiating outright long HIMS here; wait for at least one quarter of estimate revisions and margin stabilization before assuming the reset is complete. Risk/reward remains unfavorable over the next 1-2 quarters because downside can persist as targets ratchet lower.
• For investors who want exposure, use a call spread rather than stock: buy HIMS 6-12 month call spreads only after the next earnings print confirms gross margin floor and guidance credibility. This limits premium burn while keeping upside to a multiple re-rating if execution improves.
• Pair trade: long BAC / short HIMS into the analyst-reset window. BAC has already expressed the cautious view, while HIMS is more exposed to downward estimate revisions; the trade benefits if sentiment remains weak and the bar continues to move lower over the next 4-8 weeks.
• Consider a small tactical short in HIMS on any relief rally toward prior sell-side targets, with a stop above the post-earnings high. The setup is attractive only if the market re-prices the reset faster than fundamentals improve; risk is a sharp squeeze if management pre-announces stabilization.
• For longer-horizon accounts, keep HIMS on a watchlist rather than a core position and require proof that international growth and new-category retention can offset the GLP-1 mix drag. The earliest durable re-entry window is likely 2-3 quarters out, not immediately after this report.